These results deepen our understanding of the FOXQ1 profile in pan-cancer, provide important clues for building immune therapy regimens targeting FOXQ1, and significantly help to guide the exploration of FOXQ1 pathogenic mechanisms in pan-cancer. The gene discussed is FOXQ1; the disease is cancer.